Skip to content

Validation of the Quantified Myasthenia Gravis strength score (QMG Score): is it both sensitive and specific?

Validation of the Quantified Myasthenia Gravis strength score (QMG Score): is it both sensitive and specific? - Validation of the QMG Score

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31839
Enrollment
420
Registered
2008-11-25
Start date
2008-12-01
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myasthenia MG

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
12 Years to 99 Years

Inclusion criteria

Inclusion criteria: myasthenia gravis neurological disease, that affects muscle strength age over 12 years old

Exclusion criteria

Exclusion criteria: non-neurological disorder that will affect muscle strength testing (eg rheumatoid arthritis) combination of different disorders with effect on muscle strength

Design outcomes

Primary

MeasureTime frame
QMG Score and QMA Score: normal values for different diseases, adapted for age and gender.

Secondary

MeasureTime frame
QMG/QMA ratio: differences between helathy controls and patients? difference between MG and other neuromuscular diseases?

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)